WASHINGTON, Sept. 10, 2012 /PRNewswire/ -- Coronary revascularization appropriate use criteria (AUC) are now just a click away with the new SCAI Quality Improvement Toolkit (SCAI-QIT) AUC and ...

The SCAI AUC tool creates an easy-to-read document that can be included in the patient's chart and allows the doctor to document his or her justification for doing a procedure that does not ...

At SCAI 2012, Giora Weisz, MD, presented the results of PRECISE, a pivotal trial of the CorPath system (Corindus). This system consists of a robotically driven cassette into which a coronary ...

On these AUC, report Blankenship and Wiegers, the writing group included neither an ASE or a SCAI representative “nor, to our knowledge, any physician who routinely performs invasive angiography.” ...

Previously, SCAI had developed their own AUC document for peripheral artery interventions, which does provide more-specific directions about therapy and rates individual devices for interventional ...

The Society for Cardiovascular Angiography & Interventions (SCAI), the leading nonprofit medical society representing interventional cardiology (IC) is excited to formally announce that the ...

The New York State Medicaid Program recently announced that it would recoup payments from physicians and hospitals for PCI procedures considered to be “inappropriate,” according to the ...

Istaroxime has previously completed two positive Phase 2 studies in SCAI Stage B cardiogenic shock; the SEISMiC C study in SCAI Stage C cardiogenic shock is another step progressing to the ...

One of the most talked about subjects at the SCAI 2013 meeting was the Appropriate Use Criteria (AUC). There are great economic and potential implications associated with the designations of ...

Elkin says SCAI is the most accurate clinical AI tool available to date, with the most advanced version scoring 95.2% on Step 3 of the USMLE, while a GPT4 Omni tool scored 90.5% on the same test. “As ...

Multiple Programs Focus on Unmet Needs In Cardiogenic Shock & AHF Pennsylvania-based Windtree Therapeutics, Inc. (NASDAQ:WINT ...